Shen D, Vadgama J V
Department of Medicine, Charles R. Drew University of Medicine and Science, UCLA School of Medicine, Los Angeles, CA 90059, USA.
Oncol Res. 1999;11(2):63-9.
Breast cancer is a leading cancer in American women. About 7% of breast cancer is due to inheritance of mutated genes BRCA1 and BRCA2. Numerous investigations have revealed a number of mutations in BRCA1 and BRCA2 genes. The inheritance of the mutated BRCA1 or BRCA2 genes accounts for 45% and 35%, respectively, of hereditary breast cancers. A central database named Breast Cancer Information Core (BIC) has been established in the National Human Genome Research Institute (NHGRI) to coordinate the information related with BRCA1 and BRCA2 research. Nearly half of the mutations (49%) in the BRCA1 gene are frameshift mutations and the cancer-causing mutations account for 66% of all entries. However, for the BRCA2 gene frameshift mutations and cancer-causing mutations account for only 35% and 43%, respectively, of all entries. The significance of a large portion of missense sequence variants (24% of BRCA1 mutations and 47% of BRCA2 mutations) needs further evaluation. The incidence of 185delAG and 5382insC in BRCA1 gene and 6174delT in BRCA2 gene is predominantly high and the founder effect of these mutations is discussed.
乳腺癌是美国女性中主要的癌症类型。约7%的乳腺癌归因于BRCA1和BRCA2基因突变的遗传。大量研究揭示了BRCA1和BRCA2基因中的一些突变。突变的BRCA1或BRCA2基因的遗传分别占遗传性乳腺癌的45%和35%。美国国立人类基因组研究所(NHGRI)建立了一个名为乳腺癌信息核心(BIC)的中央数据库,以协调与BRCA1和BRCA2研究相关的信息。BRCA1基因中近一半的突变(49%)是移码突变,致癌突变占所有条目的66%。然而,对于BRCA2基因,移码突变和致癌突变分别仅占所有条目的35%和43%。大部分错义序列变异(BRCA1突变的24%和BRCA2突变的47%)的意义需要进一步评估。BRCA1基因中185delAG和5382insC以及BRCA2基因中6174delT的发生率主要较高,并讨论了这些突变的奠基者效应。